BEIJING, March 28 (Xinhuanet) -- A new drug named
Yervoy has been developed in the U.S. to prolong the lives of people
with the skin cancer melanoma, according to media reports Monday.

Developed by Bristol-Myers Squibb, Yervoy is in a new class of drugs
designed to fight cancer by removing molecular brakes that prevent
immune system cells from destroying tumors.

Approved by the Food and Drug Administration, Yervoy is hailed
by experts as the first drug in the melanoma field that could extend
survival in a meaningful way.

Although not normally superstitious, the portents were not promising
in the lead up to my participation in the Norwood bike ride in Croatia.Persuaded to sign up by a good friend, my training consisted
primarily of laps around Regent's Park on the bike I received from my
parents as a batmitzvah present.Over three months, my brakes broke and I lost the key to my bike lock
while it was chained. My husband and training partner broke his hand
and a bike he was due to borrow was stolen.But ignoring the warning signs, we joined 25 other riders on the cycle, which raised £32,000 for Young Norwood.